AstraZeneca rolls out online reading tool for U.S. docs; Journal ad revenue on the upswing; Sanofi unveils app for Kenyan moms;

> AstraZeneca ($AZN) launched a new online tool for U.S. doctors, DoctorsNotes, that's designed to help physicians annotate and organize their online reading. Report

> Advertising in medical journals grew by 8.7% for the first half of 2014, to $165 million, with a 3% increase in ad pages. Report

> Sanofi ($SNY) rolled out Mommy's App, a health tracker for infants, in Kenya in partnership with the Kenya Pediatric Association. Report

> The European Medicines Agency tapped Marie-Agnes Heine to lead its communication department; previously she was a communications officer with the World Health Organization. Report

> The medical communications firm Fishawack has opened a new U.S. office in San Francisco to handle West Coast clients; Fishawack expanded its East Coast team earlier this year. Report

And Finally... A bit less than half of U.S. physicians want the new iPhone with a larger, 5.5-inch screen. Report

Suggested Articles

BMS' Opdivo and Yervoy only just won their first approval in previously untreated metastatic NSCLC, but the pair is already making it two.

Takeda’s Alunbrig has arrived in previously untreated, ALK-positive NSCLC. But there’s plenty of competition waiting to greet it at the door.

Sanofi and Regeneron's blockbuster Dupixent is eyeing an approval in eosinophilic esophagitis after cutting patients' difficulty breathing.